Biotech Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and FD Development January 3, 2025
Biotech Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers January 2, 2025
Biotech U.S. FDA approves Celltrion’s STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) December 18, 2024
Biotech WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection December 12, 2024
Biotech SKAN Research Trust Secures Two Major Government Recognitions: Research Association for Scientific Research – Sec 35(1) and Scientific and Industrial Research Organization (SIRO) December 10, 2024
Biotech Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH December 9, 2024
Biotech BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) December 8, 2024